Evidence map›Paper›PMID 32444835›Full record

ReviewNature chemical biology2020

Chromatin as a key consumer in the metabolite economy.

Katharine L Diehl, Tom W Muir

Open access · greenAbstract readReview
In one paragraph

Review in Nature chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Biochemistry and regulation of histone lysine L-lactylation.Nature reviews. Molecular cell biology · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Katharine L DiehlDepartment of Chemistry, Princeton University, Princeton, NJ, USA. k.diehl@utah.edu.ORCID http://orcid.org/0000-0002-9872-7501
Tom W MuirDepartment of Chemistry, Princeton University, Princeton, NJ, USA. muir@princeton.edu.ORCID http://orcid.org/0000-0001-9635-0344
Princeton University · US

Funding

Shared Resources Core 2: Quantitative Proteomics CoreP01CA196539 · NCI · ROCKEFELLER UNIVERSITY · PI YOUNG, MICHAEL WARREN · 2015 to 2024
$17.6M
PEPTIDE AUTOINDUCERS OF STAPHYLOCOCCAL PATHOGENICITYR01AI042783 · NIAID · PRINCETON UNIVERSITY · PI MUIR, TOM · 1998 to 2021
$7.9M
Structure, Function and Applications of InteinsR37GM086868 · NIGMS · PRINCETON UNIVERSITY · PI MUIR, TOM · 2012 to 2021
$5.4M
Development and Applications of 'Designer Chromatin'R01GM107047 · NIGMS · PRINCETON UNIVERSITY · PI MUIR, TOM · 2013 to 2016
$1.2M
Epigenetic Mechanisms of Oncohistone DetoxificationF32CA206418 · NCI · PRINCETON UNIVERSITY · PI DIEHL, KATHARINE · 2016 to 2018
$168k
NCI NIH HHS F32 CA206418NCI NIH HHS P01 CA196539NIAID NIH HHS R01 AI042783NIGMS NIH HHS R01 GM107047NIGMS NIH HHS R37 GM086868
6 · The paper itself

Abstract

In eukaryotes, chromatin remodeling and post-translational modifications (PTMs) shape the local chromatin landscape to establish permissive and repressive regions within the genome, orchestrating transcription, replication, and DNA repair in concert with other epigenetic mechanisms. Though cellular nutrient signaling encompasses a huge number of pathways, recent attention has turned to the hypothesis that the metabolic state of the cell is communicated to the genome through the type and concentration of metabolites in the nucleus that are cofactors for chromatin-modifying enzymes. Importantly, both epigenetic and metabolic dysregulation are hallmarks of a range of diseases, and this metabolism-chromatin axis may yield a well of new therapeutic targets. In this Perspective, we highlight emerging themes in the inter-regulation of the genome and metabolism via chromatin, including nonenzymatic histone modifications arising from chemically reactive metabolites, the expansion of PTM diversity from cofactor-promiscuous chromatin-modifying enzymes, and evidence for the existence and importance of subnucleocytoplasmic metabolite pools.

Indexed as

Metabolic Networks and PathwaysChromatinChromatin Assembly and DisassemblyDNA DamageDNA RepairEnzymesEpigenesis, GeneticEukaryotaHistonesHumansProtein Processing, Post-TranslationalChromatinEnzymesHistones

Identifiers

PMID32444835
PMCPMC7258299
OpenAlexW3026854597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.